Dr. Alexander Fichtner, Germany
Prevention of human papillomavirus (HPV) infection in pediatric kidney (KTx) and liver transplant recipients (LTx) and in pediatric patients with advanced chronic kidney disease (CKD): a prospective, multicenter vaccine surveillance trial (HPVaxResponse study)

Daniel Dulek, United States
Multicenter Prospective Cohort Study of CMV T cell Immunity and First post-transplant CMV DNAemia in Pediatric Solid Organ Transplant Recipients

Dr. Dorota Broniszczak-Czyszek, Poland
Complete withdrawal of immunosuppression and long-term graft function in pediatric liver recipients who developed PTLD or EBV infection

Michael Green, United States
Impact of Epstein Barr Virus (EBV) status of lesions, 2016 WHO histologic grade and time of onset on outcome of Post-Transplant Lymphoproliferative Disorder (PTLD) in pediatric solid organ transplant (SOT) and hematopoietic stem cell transplant (HCT) recipients: Results of a prospective/retrospective multicenter study

Dr. Charlotte Duneton, France
Pretransplant BK Virus Immunity in Pediatric Kidney Transplantation: Predictive Markers and Role of IVIg Prophylaxis

Dr. Sonya R Kowalczyk, United States
Surveillance of Post-Transplant Lymphoproliferative Disorder in Pediatric Solid Organ Transplant Recipients

Dr. Alejandro Zarauza Santoveña, Spain
Adoptive cell therapy based on CD45RO+/RA- memory lymphocites infusions to treat BK virus-associated nefropathy in kidney transplant patients.

Dr. Sharath M Manya, United Kingdom
Neonatal acute liver failure secondary to enteroviruses: Outcome with or without liver transplantation

Dr. Sharath M Manya, United Kingdom
The role of the fungal biomarker Beta-D-Glucan (BDG) in diagnosing and guiding antifungal prescribing for fungal infections in paediatric liver and multivisceral transplant recipients